Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
- Status
- COMPLETED
- Phase
- PHASE2
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
- Status
- UNKNOWN
- Phase
- PHASE3
Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
NCI UNC Project ESCC
- Status
- TERMINATED
- Phase
- N/A
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
- Status
- UNKNOWN
- Phase
- PHASE2
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
- Status
- COMPLETED
- Phase
- N/A
Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
- Status
- COMPLETED
- Phase
- NA
Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)
- Status
- COMPLETED
- Phase
- PHASE2